Scinai Immunotherapeutics Stock Analysis

Scinai Stock Analysis Notes

About 13.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.63. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Scinai Immunotherapeutics had not issued any dividends in recent years. The entity had 1:10 split on the 21st of May 2024. Scanner Technologies Corporationration engages in the development and marketing of machinevision inspection solutions that are used in the semiconductor industry for the inspection of integrated circuits. To find out more about Scinai Immunotherapeutics contact MSc MBA at 972 8 930 2529 or learn more at https://www.scinai.com.

Scinai Immunotherapeutics Investment Alerts

Scinai Immunotherapeutics Upcoming and Recent Events

Scinai Largest EPS Surprises

View All Earnings Estimates

Scinai Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.78 M.

Scinai Profitablity

Management Efficiency

Scinai Immunotherapeutics has return on total asset (ROA) of (0.2835) % which means that it has lost $0.2835 on every $100 spent on assets. This is way below average. Scinai Immunotherapeuti's management efficiency ratios could be used to measure how well Scinai Immunotherapeuti manages its routine affairs as well as how well it operates its assets and liabilities. The Scinai Immunotherapeuti's current Return On Equity is estimated to increase to 1.50, while Return On Tangible Assets are projected to decrease to (0.39). As of now, Scinai Immunotherapeuti's Debt To Assets are increasing as compared to previous years.

Technical Drivers

As of the 6th of December, Scinai Immunotherapeuti has the Semi Deviation of 5.02, coefficient of variation of 8744.39, and Risk Adjusted Performance of 0.0174. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Scinai Immunotherapeutics, as well as the relationship between them.

Scinai Immunotherapeutics Price Movement Analysis

Scinai Immunotherapeutics Insider Trading Activities

Scinai Immunotherapeuti Predictive Daily Indicators

Scinai Immunotherapeuti Corporate Filings

Scinai Immunotherapeuti Forecast Models

Scinai Immunotherapeuti's time-series forecasting models are one of many Scinai Immunotherapeuti's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Scinai Immunotherapeuti's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Scinai Immunotherapeuti prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Scinai shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Scinai Immunotherapeuti. By using and applying Scinai Stock analysis, traders can create a robust methodology for identifying Scinai entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Scinai analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Scinai analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Scinai Immunotherapeutics stock analysis indicators help investors evaluate how Scinai Immunotherapeuti stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Scinai Immunotherapeuti shares will generate the highest return on investment. By understating and applying Scinai Immunotherapeuti stock analysis, traders can identify Scinai Immunotherapeuti position entry and exit signals to maximize returns.

When running Scinai Immunotherapeuti's price analysis, check to measure Scinai Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scinai Immunotherapeuti is operating at the current time. Most of Scinai Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of Scinai Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scinai Immunotherapeuti's price. Additionally, you may evaluate how the addition of Scinai Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.